News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News CRT 2019 One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT Yael L. Maxwell March 04, 2019
News Daily News Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing Yael L. Maxwell March 01, 2019
News Daily News New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI Shelley Wood February 19, 2019
Partner Content FFRangio and the Rise of Image-Based Fractional Flow Reserve (FFR) - CathWorks October 29, 2019
Partner Content Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention May 17, 2019